Physician profile
Thomas J Walker
NPI 1922250489
$1,612.53
in general payments reported to CMS, 2019-2025
16 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $216 · 2021: $165 · 2022: $318 · 2023: $134 · 2024: $347 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $355.35 | 2024-2025 | |
| Galderma Laboratories, L.P. | $267.74 | 2019-2025 | Dysport |
| Stryker Corporation | $220.33 | 2019-2022 | |
| Abbvie INC. | $114.40 | 2023-2024 | |
| Allergan, INC. | $106.81 | 2019-2022 | |
| Optinose US, INC. | $101.32 | 2019-2020 | |
| Merz North America, INC. | $88.28 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $77.02 | 2019-2022 | |
| Genzyme Corporation | $72.68 | 2021-2024 | |
| Intersect Ent, INC. | $64.06 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $56.42 | 2021-2023 | |
| Hikma Pharmaceuticals USA | $20.87 | 2025 | Ryaltris |
| Shire North American Group INC | $20.48 | 2019 | |
| Phadia US INC. | $18.47 | 2022 | |
| Alk-Abello, INC | $14.61 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.